Opioid Use, Abuse and Misuse Resource Center

APhA believes it is imperative that a proper balance be maintained in delivering appropriate pain management for the millions of patients with legitimate needs for controlled substances while taking steps to minimize inappropriate use and abuse.  Pharmacists possess unique knowledge about the safe and effective use of medications and about the adverse events resulting from inappropriate use. Such knowledge enables pharmacists to play an important role in patient access to opioids, but also opioid drug abuse prevention, education, and assistance.  

Opioid News
March 27, 2018
Congressional focus on opioids is an opportunity for pharmacists and their patients

Opioids remain a policy priority for the U.S. Congress, with a package of bills known as “CARA 2.0” under consideration and relevant committees holding hearings on the issue. As these conversations evolve, pharmacists are expressing current and potential contributions to these efforts. Pharmacists…

Read More
March 19, 2018
Collaborating with prescribers to treat chronic pain

Pain is an emotional condition, and a big part of addressing chronic pain is addressing its emotional component. “Having a team approach to that is fundamental,” said Noah Nesin, MD, FAAFP, vice president of medical affairs at Penobscot Community Health Care (PCHC), a federally qualified health…

Read More
March 13, 2018
Nonopioids just as good as opioids for chronic back pain, hip and knee osteoarthritis pain

Nonopioid medications are just as good as opioid medications for treating pain and pain-related function in people with chronic back pain or pain from hip or knee osteoarthritis, according to a study published online in JAMA on March 6. In the study, researchers assessed pain-related function in…

Read More
March 8, 2018
Opioid overdoses continue to rise, says latest CDC data on ED visits

The latest statistics from CDC indicate that the opioid crisis in America is not abating. According to a March CDC Vital Signs report, there were more than 142,000 suspected opioid overdoses among the 91 million emergency department (ED) visits across the United States captured in CDC’s National…

Read More
November 28, 2017
Hospitals can improve high-alert med safety procedures with self-assessment

Hospitals in the United States are required to identify and maintain active lists of high-alert medications, which isn’t hard to do. But when it comes to the next step of developing safety procedures for high-alert medications, the task can become more challenging. For example, double-checks are…

Read More
November 28, 2017
DEA mandates reduction in opioid manufacturing for 2018

DEA’s finalized annual aggregate production quotas (APQs) for 2018 mandate a 20% reduction in the amount of opiate and opioid medication—including oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine, codeine, meperidine, and fentanyl—that may be manufactured in 2018. Quotas are aimed at…

Read More